Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Synergy Pharma (SGYP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP

Pomerantz LLP is investigating claims on behalf of investors of Synergy Pharmaceuticals Inc. ("Synergy" or the "Company") (NASDAQ: SGYP). Such investors are advised to contact Robert S. Willoughby at...

SGYP : 0.31 (+9.54%)
SYNERGY PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that it filed a securities class action lawsuit in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc.

Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of those who acquired...

SGYP : 0.31 (+9.54%)
Fight Against Cancer Rages on as New Therapy Methods Arise

NEW YORK, January 25, 2019 /PRNewswire/ --

CPHI : 0.27 (-3.57%)
CLDX : 5.86 (+13.35%)
SNET : 0.0157 (+12.14%)
SGYP : 0.31 (+9.54%)
Global Irritable Bowel Syndrome Treatment Market Status, Key Trends and Foresight 2017-2026

Irritable bowel syndrome (IBS) is a gastrointestinal disorder that affects large intestine, symptom includes abdominal pain, altered bowel habits, increased gas, bloating (distention), cramping, and food...

VRX.TO : 30.80 (-3.33%)
ABT : 75.25 (+1.73%)
IRWD : 15.20 (+9.20%)
SCMP : 18.05 (+0.28%)
ALPMF : 15.0000 (-0.20%)
NVS : 89.88 (+0.97%)
SGYP : 0.31 (+9.54%)
GSK : 41.24 (+0.93%)
These 4 Healthcare Stocks Are Making Moves

CORAL GABLES, FL / ACCESSWIRE / January 4, 2019 / The is predicated on the notion that as diseases become more advanced and difficult to treat, companies responsible for creating treatment options will...

PHGI.CN : 0.830 (unch)
PHGRF : 0.6316 (+1.95%)
NVAX : 2.13 (-3.18%)
SGYP : 0.31 (+9.54%)
EPZM : 12.89 (+3.37%)
Thinking about buying stock in Apple, Randgold Resources, Histogenics Corp., Roku Inc. or Synergy Pharmaceuticals?

InvestorsObserver issues critical PriceWatch Alerts for AAPL, GOLD, HSGX, ROKU, and SGYP.

GOLD : 12.95 (+0.31%)
ROKU : 52.08 (+2.18%)
AAPL : 170.42 (-0.22%)
SGYP : 0.31 (+9.54%)
These 4 Healthcare Stocks Are Kicking Off The New Year With A Bang

CORAL GABLES, FL / ACCESSWIRE / January 2, 2019 / With the new year only a few days old, is already showing signs that this year may prove exciting for the market. Given that the industry is primed to...

GNCA : 0.50 (unch)
SGYP : 0.31 (+9.54%)
RHE : 1.23 (+1.65%)
4 Pharma Stocks Gaining Speed on Monday (12/31/18)

CORAL GABLES, FL/ ACCESSWIRE / December 31,2018 / With the new year only moments away, companies in the are working hard to create new methods and approaches for treating patients with innumerable diseases...

RAD : 0.80 (+2.56%)
ADMP : 3.12 (+0.65%)
SGYP : 0.31 (+9.54%)
4 Stocks Providing Investor Opportunity Right Now

CORAL GABLES, FL / ACCESSWIRE / December 17, 2018 / 2018 and its wild market swings are winding down as 2019 gears up. This week investors are being presented with several stocks providing volatile upside...

DFFN : 2.46 (+1.65%)
PHGI.CN : 0.830 (unch)
EVFM : 3.60 (+2.86%)
PHGRF : 0.6316 (+1.95%)
SGYP : 0.31 (+9.54%)
Cipher Pharmaceuticals Announces PLECANATIDE Accepted for Review by Health Canada

Cipher Pharmaceuticals Inc. (TSX:CPH) today announced that its New Drug Submission ("NDS") for plecanatide for irritable bowel syndrome with constipation ("IBS-C") has been accepted by Health Canada....

CPH.TO : 1.90 (-0.52%)
CPHRF : 1.3910 (-0.43%)
SGYP : 0.31 (+9.54%)
Thinking about buying stock in Lloyds Banking Group, New Age Beverages Co, Synergy Pharmaceuticals, Tilray or Uxin?

InvestorsObserver issues critical PriceWatch Alerts for LYG, NBEV, SGYP, TLRY, and UXIN.

LYG : 2.96 (+2.07%)
SGYP : 0.31 (+9.54%)
UXIN : 4.05 (+12.81%)
Bausch (BHC) Bids for Assets of Synergy Pharmaceuticals

Bausch (BHC) bids to acquire certain assets of Synergy Pharma for $200 million.

AGN : 139.07 (+0.29%)
GILD : 67.59 (+1.84%)
BHC : 25.45 (-0.20%)
SGYP : 0.31 (+9.54%)
Today's Research Reports on Trending Tickers: Milestone Scientific and Bausch Health

NEW YORK, NY / ACCESSWIRE / December 13, 2018 / Biotech stocks Milestone Scientific and Bausch Health Companies soared on Wednesday. Milestone Scientific saw big gains of over 20% on no specific news while...

MLSS : 0.37 (+2.78%)
BHC : 25.45 (-0.20%)
SGYP : 0.31 (+9.54%)
Synergy Pharmace Set to Possibly Rebound After Yesterday's Selloff of 71.24%

Synergy Pharmace (NASDAQ:SGYP) traded in a range yesterday that spanned from a low of $0.09 to a high of $0.17. Yesterday, the shares fell 71.2%, which took the trading range below the 3-day low of $0.33...

SGYP : 0.31 (+9.54%)
Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc.

Strategic Acquisition Will Enhance the Salix Gastroenterology Portfolio

SGYP : 0.31 (+9.54%)
Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced...

SGYP : 0.31 (+9.54%)
Innovate Biopharmaceuticals Strengthens Clinical Development with the Addition of Patrick H. Griffin, M.D., F.A.C.P.

Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical-stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory diseases, announced today that Patrick H....

INNT : 2.23 (+1.36%)
SGYP : 0.31 (+9.54%)
Immuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEO

Immuron Limited, (IMC or the Company), (ASX: IMC; NASDAQ: IMRN), is pleased to announce the appointment of Gary S. Jacob as Chief Executive Officer. Dr Jacob is the former Chairman, President and Chief...

IMRN : 7.96 (-2.93%)
SGYP : 0.31 (+9.54%)
Recent Analysis Shows Brown Forman, CryoLife, Aspen Group, Taylor Devices, Synergy Pharmaceuticals, and Ramco-Gershenson Properties Trust Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Brown Forman Corporation...

RPT : 13.36 (-0.30%)
BF.A : 49.32 (+1.29%)
ASPU : 4.77 (+6.24%)
CRY : 27.03 (+4.56%)
SGYP : 0.31 (+9.54%)
TAYD : 12.82 (-1.08%)
Synergy Pharmaceuticals (SGYP) Reports Q3 Loss, Misses Revenue Estimates

Synergy Pharma (SGYP) delivered earnings and revenue surprises of -7.69% and -29.04%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

SGYP : 0.31 (+9.54%)

Van Meerten Stock Picks

SecureWorks - Pick of the Day
My Stock Pick of the Day belongs to the security software company SecureWorks (SCWX).
SCWX -0.33
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar